Valuation : MedAvail Holdings, Inc.

Market Cap 7.25M 6.24M 5.87M 5.36M 10.03M 684M 10.05M 69.33M 26.9M 351M 27.21M 26.62M 1.13B P/E 2021
-1.04x
P/E 2022 -0.41x
Enterprise Value 2.88M 2.48M 2.33M 2.13M 3.98M 272M 3.99M 27.53M 10.68M 139M 10.81M 10.57M 449M EV / Sales 2021
1.74x
EV / Sales 2022 0.46x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 1.0E-6
0.05
3 years 0
Extreme 1.0E-6
9.56
5 years 0
Extreme 1.0E-6
204
10 years 0
Extreme 1.0E-6
1,039.5
Manager TitleAgeSince
Director of Finance/CFO 57 20/09/2021
Corporate Officer/Principal 45 18/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/23 Exercice

Chief Financial Officer

1,663 0.1030%
18/08/23 Free

Chief Executive Officer

250,000 0.3098%
18/08/23 Free

Chief Financial Officer

114,968 0.1425%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-100.00% 161
-0.20%-3.26%+26.90%+133.83% 121B
+2.95%-2.00%+44.31%+41.35% 35.46B
+3.22%-0.30%+39.40%+70.52% 31.42B
+1.27%-2.83%-5.67%+11.57% 29.63B
+0.18%-4.50%+49.93%-7.79% 27.05B
+0.95%-2.92%+8.51%+34.15% 25.98B
-2.04%-5.05%-24.81%+8.13% 24.68B
+0.11%-3.71%+28.15%+42.48% 24.01B
-3.54%-7.42%+433.25%+1,712.19% 23.57B
Average +0.29%-3.42%+60.00%+194.64% 34.31B
Weighted average by Cap. +0.34%-3.49%+51.74%+182.19%

Financials

2021 2022
Net sales 22.13M 19.04M 17.92M 16.37M 30.62M 2.09B 30.7M 212M 82.15M 1.07B 83.1M 81.28M 3.45B 43.11M 37.1M 34.9M 31.88M 59.64M 4.07B 59.81M 412M 160M 2.09B 162M 158M 6.73B
Net income -43.82M -37.7M -35.47M -32.4M -60.62M -4.14B -60.78M -419M -163M -2.12B -165M -161M -6.84B -47.62M -40.97M -38.55M -35.22M -65.88M -4.5B -66.06M -456M -177M -2.31B -179M -175M -7.43B
Net Debt -7.44M -6.4M -6.03M -5.5M -10.3M -703M -10.32M -71.2M -27.63M -361M -27.95M -27.34M -1.16B -4.37M -3.76M -3.54M -3.23M -6.04M -413M -6.06M -41.8M -16.22M -212M -16.41M -16.05M -682M
Logo MedAvail Holdings, Inc.
MedAvail Holdings, Inc. is a pharmacy technology and services company. The Company is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. It operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
Employees
279
  1. Stock Market
  2. Stocks
  3. MYOS Stock